Acta Medica Martiniana (May 2015)

Atomoxetine and Methylphenidate Treatment in ADHD

  • Snircova E.,
  • Hrtanek I.,
  • Kulhan T.,
  • Nosalova G.,
  • Ondrejka I.

DOI
https://doi.org/10.1515/acm-2015-0003
Journal volume & issue
Vol. 15, no. 1
pp. 20 – 26

Abstract

Read online

Objective: ADHD (Attention deficit/hyperactivity disorder) is the most common diagnosed neurobehavioral disorder in childhood and adolescence. Core symptoms of ADHD are persistent inattention, hyperactivity and impulsivity. In Slovakia, there are two specific medication choices to treat ADHD - atomoxetine and methylphenidate. Even though methylphenidate is option number one according to guidelines, the highest amount of patients are taking atomoxetine.

Keywords